Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-22-026148

Director acquired 1,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krogulski Kenneth Director 2022-03-16 Grant or award +1,000 $2.59 $2,590 184,141 D
Loading xslF345X03/doc4.xml…